Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors

Oral Diseases

Volumn 13, Issue 5, 2007, Pages 461-467

  Kumamoto, Hiroyuki ^a   Ooya, Kiyoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Akt; Ameloblastoma; PI3K; PTEN; Tooth germ

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ACANTHOMA; AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AMELOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; MEMBRANE PROTEINS; ONCOGENE PROTEIN V-AKT; PTEN PHOSPHOHYDROLASE; STATISTICS, NONPARAMETRIC;

EID: 34547842827     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01321.x     Document Type: Article

References (39)

1. Altomare DA, Testa JR (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24 : 7455 7464.
2. Ayer-le Lievre C, Stahlbom PA, Sara VR (1991). Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development 111 : 105 115.
3. Blume-Jensen P, Hunter T (2001). Oncogenic kinase signalling. Nature 411 : 355 365.
4. Cam Y, Neumann MR, Oliver L et al. (1992). Immunolocalization of acidic and basic fibroblast growth factors during mouse odontogenesis. Int J Dev Biol 36 : 381 389.
5. Chang HW, Aoki M, Fruman D et al. (1997). Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276 : 1848 1850.
6. Chen WS, Xu PZ, Gottlob K et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev 15 : 2203 2208.
7. Datta SR, Brunet A, Greenberg ME (1999). Cellular survival: a play in three Akts. Genes Dev 13 : 2905 2927.
8. Di Cristofano A, Pesce B, Cordon-Cardo C et al. (1998). Pten is essential for embryonic development and tumour suppression. Nat Genet 19 : 348 355.
9. Fruman DA, Snapper SB, Yballe CM et al. (1999). Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283 : 393 397.
10. Heikinheimo K, Voutilainen R, Happonen RP et al. (1993). EGF receptor and its ligands, EGF and TGF-alpha, in developing and neoplastic human odontogenic tissues. Int J Dev Biol 37 : 387 396.
11. Heikinheimo K, Jee KJ, Niini T et al. (2002). Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 81 : 525 530.
12. Hendarmin L, Sandra F, Nakao Y et al. (2005). TNFα played a role in induction of Akt and MAPK signals in ameloblastoma. Oral Oncol 41 : 375 382.
13. Jimenez C, Jones DR, Rodriguez-Viciana P et al. (1998). Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17 : 743 753.
14. Kumamoto H (2006). Molecular pathology of odontogenic tumors. J Oral Pathol Med 35 : 65 74.
15. Kumamoto H, Ooya K (2005a). Expression of tumor necrosis factor α, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pathol Med 34 : 287 294.
16. Kumamoto H, Ooya K (2005b). Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas. J Oral Pathol Med 34 : 565 572.
17. Kumamoto H, Kimi K, Ooya K (2001). Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 30 : 309 315.
18. Kumamoto H, Yoshida M, Ooya K (2002). Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-β and their receptors in epithelial odontogenic tumors. J Oral Pathol Med 31 : 539 548.
19. Kumamoto H, Izutsu T, Ohki K et al. (2004a). p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas. J Oral Pathol Med 33 : 292 299.
20. Kumamoto H, Takahashi N, Ooya K (2004b). K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. J Oral Pathol Med 33 : 360 367.
21. Li J, Yen C, Liaw D et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 : 1943 1947.
22. Liaw D, Marsh DJ, Li J et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 : 64 67.
23. Marsh DJ, Dahia PL, Zheng Z et al. (1997). Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16 : 333 334.
24. Mayo LD, Donner DB (2002). The PTEN, Mdm2, p53 tumor suppressor- oncoprotein network. Trends Biochem Sci 27 : 462 677.
25. Nodit L, Barnes L, Childers E et al. (2004). Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol 17 : 1062 1067.
26. Philipsen HP, Reichart PA, Slootweg PJ et al. (2005). Odontogenic tumours. In : Barnes L, Eveson JW, Reichart PA, Sidransky D, eds. WHO classification of head and neck tumours. Pathology & Genetics. Lyon : IARC Press, pp. 283 327.
27. Samuels Y, Wang Z, Bardelli A et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304 : 554.
28. Sandra F, Nakamura N, Kanematsu T et al. (2002). The role of MDM2 in the proliferative activity of ameloblastoma. Oral Oncol 38 : 153 157.
29. Sandra F, Hendarmin L, Kukita T et al. (2005). Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol 41 : 637 644.
30. Sciubba JJ, Fantasia JE, Kahn LB (2001). Tumors and cysts of the jaw. Washington, DC : Armed Forces institute of Pathology, pp. 71 99.
31. Shayesteh L, Lu Y, Kuo WL et al. (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21 : 99 102.
32. Snead ML, Luo W, Oliver P et al. (1989). Localization of epidermal growth factor precursor in tooth and lung during embryonic mouse development. Dev Biol 134 : 420 429.
33. So F, Daley TD, Jackson L, Wysocki GP (2001). Immunohistochemical localization of fibroblast growth factors FGF-1 and FGF-2, and receptors FGFR2 and FGFR3 in the epithelium of human odontogenic cysts and tumors. J Oral Pathol Med 30 : 428 433.
34. Staal SP (1987). Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A 84 : 5034 5037.
35. Stambolic V, Suzuki A, de la Pompa JL et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 : 29 39.
36. Tabata MJ, Kim K, Liu JG et al. (1996). Hepatocyte growth factor is involved in the morphogenesis of tooth germ in murine molars. Development 122 : 1243 1251.
37. Terauchi Y, Tsuji Y, Satoh S et al. (1999). Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase. Nat Genet 21 : 230 235.
38. Whitman M, Downes CP, Keeler M et al. (1988). Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332 : 644 646.
39. Yao R, Cooper GM (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267 : 2003 2006.